SCHEMBL7216285

SCHEMBL7216285

CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 1.00
▸ FBP1 P09467 1/20 0.66
▸ ERBB2 P04626 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1418279 0.81 EGFR (0.77) EGFRFBP1
SCHEMBL7222247 0.81 EGFR (1.00) EGFRFBP1ERBB2
SCHEMBL17940088 0.81 EGFR (1.00) EGFRFBP1ERBB2
SCHEMBL2995375 0.79 EGFR (0.92) EGFRFBP1
SCHEMBL6837371 0.79 EGFR (1.00) EGFR
SCHEMBL12012727 0.79 EGFR (1.00) EGFRERBB2
SCHEMBL1418145 0.78 FBP1 (0.79) EGFRFBP1ERBB2
SCHEMBL31060143 0.78 EGFR (1.00) EGFRFBP1
SCHEMBL1417946 0.77 FBP1 (0.78) EGFRFBP1
SCHEMBL8315497 0.76 EGFR (0.79) EGFRFBP1ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596726-B1 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme WARNER LAMBERT COMPANY 2003-07-22 — — US disclosed
US-5679683-A USEFUL FOR TREATING CANCER, ARTHRITIS, PSORIASIS, VASCULAR RESTENOSIS AND ANGIOGENESIS WARNER-LAMBERT COMPANY (US) 1997-10-21 — — US disclosed
EP-0741711-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1996-11-13 — — EP disclosed
WO-1995019970-A1 TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY WARNER-LAMBERT COMPANY (US) 1995-07-27 — — WO disclosed
Send feedback